Author: Bumcrot, David; Manoharan, Muthiah; Koteliansky, Victor; Sah, Dinah W Y
Title: RNAi therapeutics: a potential new class of pharmaceutical drugs Cord-id: muq3eq9v Document date: 2006_1_1
ID: muq3eq9v
Snippet: The rapid identification of highly specific and potent drug candidates continues to be a substantial challenge with traditional pharmaceutical approaches. Moreover, many targets have proven to be intractable to traditional small-molecule and protein approaches. Therapeutics based on RNA interference (RNAi) offer a powerful method for rapidly identifying specific and potent inhibitors of disease targets from all molecular classes. Numerous proof-of-concept studies in animal models of human diseas
Document: The rapid identification of highly specific and potent drug candidates continues to be a substantial challenge with traditional pharmaceutical approaches. Moreover, many targets have proven to be intractable to traditional small-molecule and protein approaches. Therapeutics based on RNA interference (RNAi) offer a powerful method for rapidly identifying specific and potent inhibitors of disease targets from all molecular classes. Numerous proof-of-concept studies in animal models of human disease demonstrate the broad potential application of RNAi therapeutics. The major challenge for successful drug development is identifying delivery strategies that can be translated to the clinic. With advances in this area and the commencement of multiple clinical trials with RNAi therapeutic candidates, a transformation in modern medicine may soon be realized.
Search related documents:
Co phrase search for related documents- action mechanism and liver cell: 1, 2
- action mechanism and liver enzyme: 1
- action mechanism and low density: 1, 2, 3, 4
- action mechanism and low density lipoprotein: 1, 2
- acute respiratory syndrome and liver cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- acute respiratory syndrome and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- acute respiratory syndrome and lna nucleic acid: 1, 2
- acute respiratory syndrome and local administration: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory syndrome and local delivery: 1, 2, 3, 4, 5, 6, 7
- acute respiratory syndrome and low density: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
- acute respiratory syndrome and low density lipoprotein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute respiratory syndrome and macular degeneration: 1, 2, 3, 4, 5
- acute respiratory syndrome and macular edema: 1, 2, 3, 4
- liver enzyme and low density: 1, 2, 3
- liver enzyme and low density lipoprotein: 1, 2, 3
- local delivery and low density: 1
- local delivery and low density lipoprotein: 1
Co phrase search for related documents, hyperlinks ordered by date